等待开盘 10-24 09:30:00 美东时间
+0.600
+0.53%
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
10-10 11:36
JP Morgan analyst Jimmy Bhullar maintains Palomar Hldgs (NASDAQ:PLMR) with a Overweight and lowers the price target from $158 to $137.
10-09 21:48
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08
Evercore ISI Group analyst David Motemaden maintains Palomar Hldgs (NASDAQ:PLMR) with a In-Line and lowers the price target from $168 to $134.
10-01 23:20
Keefe, Bruyette & Woods analyst Meyer Shields maintains Palomar Hldgs (NASDAQ:PLMR) with a Outperform and lowers the price target from $204 to $172.
08-08 19:03
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46
In the current market session, Palomar Hldgs Inc. (NASDAQ:PLMR) share price is ...
08-07 06:02
Palomar Holdings shares are trading lower after the company reported a Q2 sales...
08-06 01:57
Palomar Hldgs (NASDAQ:PLMR) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.72 by 2.44 percent. This is a 40.8 percent increase over earnings of $1.25 per share from the
08-05 04:13
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32